Loading...
AmerisourceBergen Corporation reported a 7.9% increase in revenue to $49.2 billion for the fourth quarter of fiscal year 2020. GAAP diluted EPS was $(23.74), while adjusted diluted EPS increased 17.4% to $1.89. The company recorded a $6.6 billion expense accrual related to opioid lawsuits.
Revenue increased 7.9% to $49.2 billion.
GAAP diluted EPS was $(23.74).
Adjusted diluted EPS increased 17.4% to $1.89.
The company recorded a $6.6 billion expense accrual related to opioid lawsuits.
AmerisourceBergen introduced its fiscal year 2021 financial guidance, expecting revenue growth in the mid-single digit percent range and adjusted diluted earnings per share to be in the range of $8.20 to $8.45.